Abstract
Breast cancers are widely prevalent in females worldwide and their diagnosis is effectively facilitated by the analysis of various hormone receptors and certain biomarkers. One of the key biomarkers is the proliferation marker Ki-67 which is a nucleoprotein used for predicting these cancers. This study was carried out to analyse the pattern of presentation of Ki-67 in breast cancer.This cross-sectional, retrospective, record based study was carried out among 100 resected breast cancer specimens. Haemotoxylin and Eosin stained slide cut from formalin fixed paraffin wax embedded, resected specimens of breast carcinoma were analyzed. The histological diagnosis of tumor was diagnosed as per WHO classification. The positive or negative immunohistochemical expression of Estrogen, progesterone and Androgen receptors in addition were evaluated using standard protocol. Ki-67 expression was also analyzed and correlated with the hormonal receptor presentation.Ki-67 was graded as <14% and >14%. Significantly high expression of Ki-67 was witnessed in 61% of the specimens. As far as the other biomarkers were examined, negative expressions of ER, PR, Her2neu and AR were strongly correlating to Ki-67 expression (90.5%. 86.8%, 81.1% and 100%) respectively. However, the observed difference was statistically not significant when compared to the other biomarkers but statistically significant as an independent prognostic marker.Our study has succinctly elaborated that Ki-67 can be used as an efficient and independent biomarker to determine the survival outcomes of breast cancers. Considering its role in establishing therapeutic protocols, further research is required to evaluate the impact of Ki-67 expression at the molecular level.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.